Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214571) titled 'A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease' on Oct. 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Shionogi

Condition: Respiratory Syncytial Virus Infections

Intervention: Drug: S-337395

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: December 1, 2025

Target Sample Size: 192

To know ...